A broad scope of Imperacer case studies and peer-reviewed publications are available upon request.

Ultra Sensitive Cytokine Quantificationrequest reprint
Imperacer® (Immuno-PCR) Method Development and Validation for Ultra Sensitive Quantification of Interferon Gamma in Human Plasma to Support Clinical Phase I of a Cancer Vaccine Candidaterequest reprint
Highly Sensitive Cytokine Quantification using Imperacer®, an Immuno-PCR based Ligand-Binding Assay Systemrequest reprint
Development and Validation of an Ultra Sensitive Imperacer (Immuno-PCR) Method for Quantification of Human Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)request reprint
Clinical Biomarker Quantification: Novel Tools for Pharmacodynamic Applicationsrequest reprint
Challenges in Developing a Sensitive PD Assay–From Tool Selection to Technologies Evaluationrequest reprint
Detecting Antigens by Quantitative Immuno-PCRrequest reprint
An Ultra Sensitive Immuno-qPCR Assay for Quantitation of Intact Pegylated Interferon Beta-1a in Human Serumrequest reprint
Feasibility of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosisrequest reprint
Imperacer® pTau Microsampling Bioanalytical Approach Supports Transgenic Mouse CSF Measurementrequest reprint
Ultrasensitive Multiparameter Biomarker Quantification in Microsampling Support request reprint
Ultrasensitive Biomarker Quantification in Dried Blood Spot Samplesrequest reprint
Phase-I “Proof of Principle”: Immunization with Virosome-Gp41-Derived Antigen Induces Mucosal Antibodies with Antiviral Properties to Reduce Risk of HIV-1 Infectionrequest reprint
Development and GLP-Validation of Imperacer® (Immuno-PCR) Methods for Ultra sensitive Quantification of Mucosal Antibodies in Support of Phase-I Clinical Trial for a Novel Vaccination Strategy in Preventing HIV Infectionrequest reprint
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomesrequest reprint
Imperacer® (Immuno-PCR) Method Development and Validation for Ultra Sensitive Quantification of Interferon Gamma in Human Plasma to Support Clinical Phase I of a Cancer Vaccine Candidaterequest reprint
Detection of Rotavirus from Stool Samples using a Standardized Immuno-PCR (Imperacer) Method with End-Point and Real-Time Detectionrequest reprint
Analysis of the Effects of Androgens and Training on Myostatin Propeptide and Follistatin Concentrations in Blood and Skeletal Muscle using Highly Sensitive Immuno-PCRrequest reprint
Modulation of Follistatin and Myostatin Propeptide by Anabolic Steroids and Genderrequest reprint
An Experimental Mouse Model to Establish Tropheryma Whipplei as a Diarrheal Agentrequest reprint
Immuno-PCR-a New Tool for Paleomicrobiology: the Plague Paradigmrequest reprint
Development and Assessment of Sensitive Immuno-PCR Assays for the Quantification of Cerebrospinal Fluid Three- and Four- Repeat Tau Isoforms in Tauopathiesrequest reprint
Phase I Trial of Intravenous Aviscumine (rViscumin) in Patients with Solid Tumors: a Study of the European Organization for Research and Treatment of Cancer New Drug Development Grouprequest reprint
Immuno-PCR based Quantification of Multiple Phosphorylated Tau-Epitopes linked to Alzheimer's Diseaserequest reprint
Imperacer® pTau Microsampling Bioanalytical Approach Supports Transgenic Mouse CSF Measurementrequest reprint
Blood Monocyte Levels of New Mid-Domain Beta-Amyloid-Degradation-Based Peptide Correlates Strongly with CSF Biomarkersrequest reprint
Immuno-PCR for the Early Serological Diagnosis of an Acute Infectious Disease: the Q Fever Paradigmrequest reprint

PD

Clinical Biomarker Quantification: Novel Tools for Pharmacodynamic Applicationsrequest reprint
Challenges in Developing a Sensitive PD Assay–From Tool Selection to Technologies Evaluationrequest reprint

Please feel free to contact Chimera Biotec’s team of dedicated scientists for more in-depth information. We are looking forward to provide you with the immunoassay to exceed your highest expectations.